机器学习用于查和预测儿童药物的可用性:一个横截面调查研究
1School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China.
机器学习准确地预测了影响儿童药物可用性的因素. 关键问题包括有限的儿科药物形式,高成本和不平等的医疗资源分配,影响获取.
科学领域:
- 卫生政策 卫生政策
- 儿科药理学 儿科药理学
- 医疗保健中的机器学习
背景情况:
- 确保儿童药物可用性对于有效的儿科医疗保健至关重要.
- 现有的政策可能无法充分解决儿童药物获取的独特挑战.
- 需要基于数据的方法来识别和优先考虑影响药物可用性的因素.
研究的目的:
- 确定影响儿童药物可用性的关键因素.
- 开发和验证用于预测药物可用性的机器学习模型.
- 为改善儿科药物政策提供经验基础.
主要方法:
- 在中国12个省份进行了一项横截面调查,涉及25家公立医院.
- 来自医生的数据被随机分为培训 (70%) 和验证 (30%) 集.
- 开发了三种机器学习模型 (随机森林,物流回归,XGBoost),并使用ROC曲线和AUC进行了比较.
主要成果:
- XGBoost模型实现了最高的预测性能 (AUC=0.915),超过了RF (AUC=0.902) 和LR (AUC=0.890).
- 确定的重要因素包括儿科特异性剂型的稀缺性,药物负担能力,公众对药物安全的认识,医疗资源的分配不均,以及医生经验.
- 开发了一个名图和临床影响曲线,以评估预测模型的实际实用性.
结论:
- XGBoost模型有效地识别了影响儿科药物可用性的关键因素.
- 解决专用儿科配方的有限可用性和提高负担能力至关重要.
- 加强公共教育和优化医疗资源分配对于改善儿童获得必要药物的机会至关重要.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
相关概念视频
Analysis of Population Pharmacokinetic Data
Factors Affecting Drug Response: Overview
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Discovery: Overview
